- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x BZJ: 3-hydroxynaphthalene-2-carboxylic acid(Non-covalent)
BZJ.2: 8 residues within 4Å:- Chain A: F.150, Y.159, M.162, T.163, K.166, M.200, L.219
- Ligands: NAD.1
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.150, A:Y.159, A:L.219
- Salt bridges: A:K.166
- pi-Stacking: A:F.150, A:F.150, A:Y.159, A:Y.159
BZJ.5: 8 residues within 4Å:- Chain B: F.150, Y.159, M.162, T.163, K.166, M.200, L.219
- Ligands: NAD.4
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:F.150, B:Y.159, B:L.219
- Salt bridges: B:K.166
- pi-Stacking: B:F.150, B:F.150, B:Y.159, B:Y.159
BZJ.8: 8 residues within 4Å:- Chain C: F.150, Y.159, M.162, T.163, K.166, M.200, L.219
- Ligands: NAD.7
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:F.150, C:Y.159, C:L.219
- Salt bridges: C:K.166
- pi-Stacking: C:F.150, C:F.150, C:Y.159, C:Y.159
BZJ.11: 8 residues within 4Å:- Chain D: F.150, Y.159, M.162, T.163, K.166, M.200, L.219
- Ligands: NAD.10
8 PLIP interactions:8 interactions with chain D- Hydrophobic interactions: D:F.150, D:Y.159, D:L.219
- Salt bridges: D:K.166
- pi-Stacking: D:F.150, D:F.150, D:Y.159, D:Y.159
- 4 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
EPE.3: 6 residues within 4Å:- Chain A: D.43, R.44, L.45, R.46, E.63, H.71
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:L.45, A:R.46
- Water bridges: A:L.47
- Salt bridges: A:E.63, A:E.63
EPE.6: 6 residues within 4Å:- Chain B: D.43, R.44, L.45, R.46, E.63, H.71
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:L.45, B:R.46
- Water bridges: B:L.47
- Salt bridges: B:E.63, B:E.63
EPE.9: 6 residues within 4Å:- Chain C: D.43, R.44, L.45, R.46, E.63, H.71
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:L.45, C:R.46
- Water bridges: C:L.47
- Salt bridges: C:E.63, C:E.63
EPE.12: 6 residues within 4Å:- Chain D: D.43, R.44, L.45, R.46, E.63, H.71
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:L.45, D:R.46
- Water bridges: D:L.47
- Salt bridges: D:E.63, D:E.63
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sabbah, M. et al., Fragment-Based Design ofMycobacterium tuberculosisInhA Inhibitors. J.Med.Chem. (2020)
- Release Date
- 2020-04-22
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.75 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 4 x BZJ: 3-hydroxynaphthalene-2-carboxylic acid(Non-covalent)
- 4 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sabbah, M. et al., Fragment-Based Design ofMycobacterium tuberculosisInhA Inhibitors. J.Med.Chem. (2020)
- Release Date
- 2020-04-22
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A